Ozanemolistat (Ozanemax)
Product detail for Ozanemolistat, INN: ozanemolistat. Therapeutic area: Rare Disease. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-026
INN
ozanemolistat
Therapeutic Area
Rare Disease
Status
Active
Owner
Tomoko Ikeda
Created
2022-12-27
Last Updated
2024-01-01
Markets
5
Presentations
| Form | Strength | Route |
|---|---|---|
| Powder for injection | 0.5 mg | Inhalation |
| Inhalation powder | 400 mg | Topical |
| Soft capsule | 5 mg/mL | Topical |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-011 | Infectivir phosphate | infectivir | 86267-30-5 | biologic | Active |
| SUB-020 | Erenumabix | erenumabix | 80035-23-4 | biologic | Active |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| HC-2024-0026 | Sweden | sNDA | Pending | Dmitri Volkov | 2022-08-10 |
| TITCK-2024-0056 | Sweden | Label Update | Approved | Carlos Mendez | 2023-11-04 |
| HC-2024-0086 | Sweden | Type II Variation | Pending | Lieselotte van der Berg | 2023-02-25 |